Application 077331
- Type
- ANDA
- Sponsor
- SUN PHARM INDS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 1MG BASE/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077331-001 | OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2008-03-04 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A077331-001 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2008-03-04 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A077331-001 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2008-03-04 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A077331-001 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2008-03-04 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sandostatin | OCTREOTIDE ACETATE | Novartis Pharmaceuticals Corporation | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 2026-07-22 | Warnings, Adverse reactions | OCTREOTIDE ACETATE |
| Octreotide Acetate | OCTREOTIDE ACETATE | GLENMARK PHARMACEUTICALS INC., USA | 387d7f8d-9762-4f6b-99e1-bdc50b8a1633 | 2026-01-30 | Warnings, Adverse reactions | Octreotide Acetate OCTREOTIDE ACETATE |
| OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | Mylan Institutional LLC | e5c21813-4714-4f23-be8b-765bd58f63b3 | 2026-01-21 | Warnings, Adverse reactions | OCTREOTIDE ACETATE OCTREOTIDE ACETATE |
| Sandostatin LAR Depot | OCTREOTIDE ACETATE | Novartis Pharmaceuticals Corporation | d0b7fe9e-7000-4b79-ba3b-291ce92c14f9 | 2025-12-22 | Warnings, Adverse reactions | OCTREOTIDE ACETATE |
| OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | Hainan Shuangcheng Pharmaceuticals Co., Ltd. | ab9b0d3d-4dab-4c5b-9c23-3a14f8fcfcde | 2025-06-25 | Warnings, Adverse reactions | OCTREOTIDE ACETATE OCTREOTIDE ACETATE |
| BYNFEZIA Pen | OCTREOTIDE ACETATE | Sun Pharmaceutical Industries, Inc. | 20ed4e79-ad4c-426f-859d-83790c00439b | 2025-02-21 | Warnings, Adverse reactions | OCTREOTIDE ACETATE |
| Octreotide Acetate | OCTREOTIDE ACETATE | Meitheal Pharmaceuticals, Inc. | 01962c67-e551-47b6-a276-e1ae1860d2a4 | 2025-01-16 | Warnings, Adverse reactions | Octreotide Acetate OCTREOTIDE ACETATE |
| OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ffaf9462-cdd8-433b-8b03-464a35577fe9 | 2024-12-03 | Warnings, Adverse reactions | OCTREOTIDE ACETATE OCTREOTIDE ACETATE |
| Octreotide Acetate | OCTREOTIDE ACETATE | Teva Pharmaceuticals, Inc. | d9739ea6-74de-4a41-a806-6e827a23cedb | 2024-07-30 | Warnings, Adverse reactions | Octreotide Acetate OCTREOTIDE ACETATE |
| Octreotide Acetate | OCTREOTIDE ACETATE | Gland Pharma Limited | 884e4287-a4d8-4a6e-8d99-dbe5e88875b9 | 2024-07-29 | Warnings, Adverse reactions | Octreotide Acetate OCTREOTIDE ACETATE |
| Octreotide Acetate | OCTREOTIDE ACETATE | Gland Pharma Limited | 2344ae7a-c2f0-433b-9133-1dcb16bb18a0 | 2024-07-25 | Warnings, Adverse reactions | Octreotide Acetate OCTREOTIDE ACETATE |
| Octreotide Acetate | OCTREOTIDE ACETATE | Mylan Institutional LLC | 2d78d5d1-77b2-4da1-98d4-d9c36e743ce2 | 2024-07-15 | Warnings, Adverse reactions | Octreotide Acetate OCTREOTIDE ACETATE |
| Octreotide | OCTREOTIDE ACETATE | Fresenius Kabi USA, LLC | d6a9a800-889d-417f-b533-1913197d0022 | 2024-05-23 | Warnings, Adverse reactions | OCTREOTIDE ACETATE |
| Octreotide | OCTREOTIDE ACETATE | Fresenius Kabi USA, LLC | f278f0d8-4062-420a-97c3-3a8b88253a08 | 2024-05-07 | Warnings, Adverse reactions | OCTREOTIDE ACETATE |
| Octreotide Acetate | OCTREOTIDE ACETATE | Hikma Pharmaceuticals USA Inc. | 9502860d-0261-4d69-a4be-827a5376d356 | 2024-03-01 | Warnings, Adverse reactions | Octreotide Acetate OCTREOTIDE ACETATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.